The Internally Truncated LRP5 Receptor Presents a Therapeutic Target in Breast Cancer

Peyman Björklund, Jessica Svedlund, Anna-Karin Olsson et al. · 2009

Read The Internally Truncated LRP5 Receptor Presents a Therapeutic Target in Breast Cancer by Peyman Björklund, Jessica Svedlund, Anna-Karin Olsson et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004243.txt.

Description

Peyman Björklund and colleagues published this breast cancer study in PLOS ONE in 2009. Breast cancer arises when genes are deregulated by changes in the genome or its packaging. The WNT and beta-catenin signalling pathway is often over-active in breast tumours, yet mutations in the pathway's own parts are rare there.

The team studied an internally truncated form of the receptor LRP5, a shortened version missing a middle section. They present it as a therapeutic target in breast cancer. A shortened receptor that tumours depend on offers a mark that healthy tissue may lack.

Catalog record

CREATORPeyman Björklund, Jessica Svedlund, Anna-Karin Olsson et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004243

Browse the full library · About the Tower of Babel